Novavax’s post-Covid path ran into a speed bump Wednesday, as the company announced a clinical hold on its Covid-influenza ...

Investors have been placing bets into startups that help members of low-income households on Medicaid insurance get care. A ...

Almost a year ago, Sanofi made history for the wrong reasons. Last October, CEO Paul Hudson announced strategic changes ...

Starboard Value may have lost its first skirmish with Pfizer. But the activist investor has a track record of protracted, ...

Takeda will not move forward with Wave Life Sciences on a Huntington’s disease drug, ending their collaboration that first ...

GSK on Tuesday unveiled a lawsuit filed against Moderna in Delaware federal court, alleging that its patented inventions ...

Stem cell biologist William Rust has been quietly working on a cure for diabetes for more than a decade. Later this year, ...

Plus, news about TenNor Therapeutics, Gan & Lee Pharmaceuticals, Orasis and Optus Pharmaceuticals: Exscientia receives $15M milestone from Sanofi: The companies are advancing two programs as ...

Neurogastrx believes its drug could treat one of the most troublesome side effects of one of the industry's biggest blockbusters. On Wednesday, the Boston-area biotech said that its experimental drug ...

Months after Purdue Pharma’s bankruptcy plan was foiled by the Supreme Court, its previous owners are bracing for a legal ...